Summary of Study ST000644
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000459. The data can be accessed directly via it's Project DOI: 10.21228/M8QP56 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
Study ID | ST000644 |
Study Title | Trace 13C-glucose, 13C-glutamine, and 13C-serine in genetically engineered pancreatic cell lines through ceramides (part III) |
Study Summary | Trace 13C-glucose, 13C-glutamine, and 13C-serine in genetically engineered pancreatic cell lines through ceramides |
Institute | Mayo Clinic |
Last Name | Lunt |
First Name | Sophia |
Address | Michigan State University 410B Biochemistry Building 603 Wilson Road East Lansing, MI 48824 |
sophia@msu.edu | |
Phone | 517-432-4886 |
Submit Date | 2017-06-23 |
Analysis Type Detail | LC-MS |
Release Date | 2019-07-17 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Combined analysis:
Analysis ID | AN000976 |
---|---|
Analysis type | MS |
Chromatography type | Reversed phase |
Chromatography system | Waters Acquity |
Column | Waters Acquity BEH C8 (150 x 2mm,1.7um) |
MS Type | ESI |
MS instrument type | QTOF |
MS instrument name | Agilent 6550 QTOF |
Ion Mode | POSITIVE |
Units | % enrichment: MPE |
Chromatography:
Chromatography ID: | CH000701 |
Instrument Name: | Waters Acquity |
Column Name: | Waters Acquity BEH C8 (150 x 2mm,1.7um) |
Chromatography Type: | Reversed phase |